Skip to main content
Premium Trial:

Request an Annual Quote

Premaitha, Ampath Sign Agreement for NIPT in South Africa

NEW YORK (GenomeWeb) – Premaitha Health announced today that it has signed an agreement with Ampath group to offer Premaitha’s Iona test in South Africa, where the UK firm has selected Barker Medical as its distributor.

Premaitha's Iona noninvasive prenatal test predicts a fetus' risk of having genetic conditions such as Down's syndrome. Clinicians perform the test on a maternal blood sample, which contains traces of fetal DNA, and analyze the sample using next-generation DNA sequencing.

Ampath will install an NIPT center at its national reference laboratory in the Gauteng province, which will service major cities including Johannesburg.

Premaitha believes Ampath will be among the first laboratories in South Africa to offer a CE-IVD accredited NIPT system and will act as a hub, offering services to its national network of hospitals and clinics.

"South Africa is another strategically important region as we build our global footprint and further de-risk our business," Premaitha CEO Stephen Little said in a statement.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.